UY26251A1 - CRYSTALLINE FORM III OF N- (4- (5- DIMETILAMINONAFTALEN-1- SULFONILAMINO) FENIL) -3 - HIDROXI-2, 2- DIMETILPROPIONAMIDA - Google Patents

CRYSTALLINE FORM III OF N- (4- (5- DIMETILAMINONAFTALEN-1- SULFONILAMINO) FENIL) -3 - HIDROXI-2, 2- DIMETILPROPIONAMIDA

Info

Publication number
UY26251A1
UY26251A1 UY26251A UY26251A UY26251A1 UY 26251 A1 UY26251 A1 UY 26251A1 UY 26251 A UY26251 A UY 26251A UY 26251 A UY26251 A UY 26251A UY 26251 A1 UY26251 A1 UY 26251A1
Authority
UY
Uruguay
Prior art keywords
crystalline form
form iii
sulfonilamino
dimetilpropionamida
dimetilaminonaftalen
Prior art date
Application number
UY26251A
Other languages
Spanish (es)
Inventor
Dr Grunenberg Dr Andr Folkerts
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of UY26251A1 publication Critical patent/UY26251A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Forma cristalina III de la N- (4- (5- dimetilaminonaftalen-1-sulfonilamino) fenil) -3- hidroxi-2, 2, dimetilpropionamida (DNSP). La presente invención se refiere a los compuestos de fórmula (I) a un procedimiento para su preparación, a los medicamentos que los contienen, así como su uso para el tratamiento de infecciones virales, especialmente de infecciones por citomegalovirus.Crystalline form III of N- (4- (5-dimethylaminonaphthalen-1-sulfonylamino) phenyl) -3-hydroxy-2,2, dimethylpropionamide (DNSP). The present invention relates to the compounds of formula (I) to a process for their preparation, to the medicines that contain them, as well as their use for the treatment of viral infections, especially cytomegalovirus infections.

UY26251A 1999-07-21 2000-07-19 CRYSTALLINE FORM III OF N- (4- (5- DIMETILAMINONAFTALEN-1- SULFONILAMINO) FENIL) -3 - HIDROXI-2, 2- DIMETILPROPIONAMIDA UY26251A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19934295A DE19934295A1 (en) 1999-07-21 1999-07-21 New thermodynamically stable crystal modification III of N-phenyl-naphthalene-sulfonamide derivative, is an antiviral agent especially useful for treating cytomegalovirus infections

Publications (1)

Publication Number Publication Date
UY26251A1 true UY26251A1 (en) 2001-01-31

Family

ID=7915608

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26251A UY26251A1 (en) 1999-07-21 2000-07-19 CRYSTALLINE FORM III OF N- (4- (5- DIMETILAMINONAFTALEN-1- SULFONILAMINO) FENIL) -3 - HIDROXI-2, 2- DIMETILPROPIONAMIDA

Country Status (8)

Country Link
AR (1) AR024797A1 (en)
AU (1) AU6562600A (en)
CO (1) CO5180571A1 (en)
DE (1) DE19934295A1 (en)
GT (1) GT200000114A (en)
PE (1) PE20010382A1 (en)
UY (1) UY26251A1 (en)
WO (1) WO2001007404A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780794B2 (en) 2000-01-20 2004-08-24 Honeywell International Inc. Methods of bonding physical vapor deposition target materials to backing plate materials
US6698647B1 (en) 2000-03-10 2004-03-02 Honeywell International Inc. Aluminum-comprising target/backing plate structures
US7371906B2 (en) 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
EP2481540B1 (en) 2011-01-28 2017-11-01 Schelling Anlagenbau GmbH Device for sawing at least two plate or plate stack shaped workpieces

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2420799A (en) * 1998-01-23 1999-08-09 Bayer Aktiengesellschaft Novel naphthyl-substituted and anilide-substituted sulfonamides

Also Published As

Publication number Publication date
AR024797A1 (en) 2002-10-23
GT200000114A (en) 2002-01-01
CO5180571A1 (en) 2002-07-30
WO2001007404A1 (en) 2001-02-01
DE19934295A1 (en) 2001-01-25
AU6562600A (en) 2001-02-13
PE20010382A1 (en) 2001-06-11

Similar Documents

Publication Publication Date Title
UY26872A1 (en) DERIVATIVES OF THE 4- PIRIDINE PHENYL
ECSP034744A (en) N-REPLACED N-REPLACED NMDA / NR2B ANTAGONISTS
BR0010555A (en) Neuraminidase Inhibitors
BR0108893B1 (en) pharmaceutical composition containing azetidine derivatives, azetidine derivative compound, and process for the preparation of compounds.
HN2003000348A (en) BENZOFURAN COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND VIRAL INFECTION OF HEPATITIS C AND ASSOCIATED ILLNESSES.
ATE260275T1 (en) SUBSTITUTED THIEN-3-YL-SULFONYLAMINO(THIO)CARBONYL-TRIAZOLINE(THI)ONE
UY29919A1 (en) SUBSTITUTED DERIVATIVES OF 3,4-DIHYDROISOQUINOLIN-1-AMINO-TRIFLUOROACETATE, ITS PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS
HRP20050390A2 (en) Substituted benzoxazinones and uses thereof
AR048741A1 (en) DERIVATIVES OF OMEGA-CARBOXIARIL DIFENIL UREA REPLACED
AR063707A1 (en) CERTAIN AMIDAS REPLACED, THE USE OF THE SAME FOR THE TREATMENT OF DISEASES MEDIATED BY THE INHIBITION OF THE ACTIVITY OF BTK AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM.
MX9404749A (en) PHENYL HETERO CYCLES AS COX-2 INHIBITORS.
ECSP034865A (en) OPTICAL RESOLUTION OF (1-BENZILO-4-METHYLOPIPERIDINE-3-IL) -METILAMINE AND ITS USE FOR THE PREPARATION OF PIRROLO DERIVATIVES 2,3-PYRIMIDINE AS PROTEIN KINASE INHIBITORS
BR0002515A (en) 4-arylpiperidine derivatives for the treatment of pruritus
ES2136037B1 (en) SULFAMIDE-METALOPROTEASE INHIBITORS
BR0002518A (en) 4-arylpiperidine derivatives for the treatment of pruritus
BRPI0408353A (en) compound, pharmaceutical composition, methods for the treatment of susceptible neoplasms and for the treatment of viral infections, and, use of a compound
ECSP034917A (en) NEW DERIVATIVES OF SULFONIC ACID
UY27700A1 (en) OXO COMPOUNDS - AZABYCLES.
UY27852A1 (en) DIFENILAZATIDINONAS CATIONICAMENTE REPLACED, PROCEDURE FOR PREPARATION, MEDICINES THAT UNDERSTAND THESE COMPOUNDS AND THEIR USE.
BRPI0415203A (en) restructured pentanols, a process for their production and use as anti-inflammatory agents
PA8568101A1 (en) INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE
ES2169242T3 (en) 2-AMINO-BENZOXAZINONES FOR THE TREATMENT OF VIRAL INFECTIONS.
DK1644389T3 (en) Pyrinidine compounds with phosphonate groups as antiviral nucleotide analogues
AR053560A1 (en) ANTIBACTERIAL COMPOUNDS OF 3,3 'DIALCOXI-2,2' -DIHIDROXI -1,1 '-BIFENILO 5,5' DISUSTITUTED AND RELATED METHODS
DOP2006000240A (en) A PHOSPHODIESTERASE-4 4-OXO-1- (3-REPLACED PHENYL) INHIBITOR -1,4-DIHIDRO-1,8-NAFTIRIDIN-3-CARBOXAMIDE AND A PREPARATION PROCEDURE OF THE SAME

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20101201